4GB3 image
Entry Detail
PDB ID:
4GB3
Keywords:
Title:
Human coxsackievirus B3 strain RD coat protein
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2012-07-26
Release Date:
2012-09-26
Method Details:
Experimental Method:
Resolution:
2.74 Å
R-Value Free:
0.33
R-Value Work:
0.33
R-Value Observed:
0.33
Space Group:
H 3 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:coat protein 1
Chain IDs:A (auth: 1)
Chain Length:281
Number of Molecules:1
Biological Source:Human coxsackievirus B3
Polymer Type:polypeptide(L)
Description:coat protein 2
Chain IDs:B (auth: 2)
Chain Length:263
Number of Molecules:1
Biological Source:Human coxsackievirus B3
Polymer Type:polypeptide(L)
Description:coat protein 3
Chain IDs:C (auth: 3)
Chain Length:238
Number of Molecules:1
Biological Source:Human coxsackievirus B3
Polymer Type:polypeptide(L)
Description:coat protein 4
Chain IDs:D (auth: 4)
Chain Length:68
Number of Molecules:1
Biological Source:Human coxsackievirus B3
Primary Citation
The Crystal Structure of a Coxsackievirus B3-RD Variant and a Refined 9-Angstrom Cryo-Electron Microscopy Reconstruction of the Virus Complexed with Decay-Accelerating Factor (DAF) Provide a New Footprint of DAF on the Virus Surface.
J.Virol. 86 12571 12581 (2012)
PMID: 22973031 DOI: 10.1128/JVI.01592-12

Abstact

The coxsackievirus-adenovirus receptor (CAR) and decay-accelerating factor (DAF) have been identified as cellular receptors for coxsackievirus B3 (CVB3). The first described DAF-binding isolate was obtained during passage of the prototype strain, Nancy, on rhabdomyosarcoma (RD) cells, which express DAF but very little CAR. Here, the structure of the resulting variant, CVB3-RD, has been solved by X-ray crystallography to 2.74 Å, and a cryo-electron microscopy reconstruction of CVB3-RD complexed with DAF has been refined to 9.0 Å. This new high-resolution structure permits us to correct an error in our previous view of DAF-virus interactions, providing a new footprint of DAF that bridges two adjacent protomers. The contact sites between the virus and DAF clearly encompass CVB3-RD residues recently shown to be required for binding to DAF; these residues interact with DAF short consensus repeat 2 (SCR2), which is known to be essential for virus binding. Based on the new structure, the mode of the DAF interaction with CVB3 differs significantly from the mode reported previously for DAF binding to echoviruses.

Legend

Protein

Chemical

Disease

Primary Citation of related structures